PTK2 and neoplasm: Rho-ROCK signaling is involved with migration, controlling the organization of actin cytoskeleton and cell motility by activating a number of downstream targets [60], while this increased FAK expression and decreased Src expression contributes to the tumor cells being able to bind to the bone ECM and establish in the bone microenvironment.